INFOTOPIA INC
SB-2/A, EX-5.1, 2000-10-19
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: INFOTOPIA INC, SB-2/A, 2000-10-19
Next: INFOTOPIA INC, SB-2/A, EX-23.1, 2000-10-19



<PAGE>   1
                        [Bondy & Schloss LLP Letterhead]

                                   EXHIBIT 5.1

                                                October , 2000

The Board of Directors
Infotopia, Inc.
218 Tearall Road
Raynham, Massachusetts 02767

         Re: Infotopia, Inc. Registration Statement on Form SB-2

Gentlemen:

         You have requested our opinion with respect to the public offering for
resale by certain shareholders of Infotopia, Inc., a Nevada corporation (the
"Company"), pursuant to a Registration Statement (the "Registration Statement")
on Form SB-2, under the Securities Act of 1933, as amended (the "Act"), of up to
64,253,203 shares of common stock (the "Shares"), $.001 par value per share.

         We have examined originals, or copies certified or otherwise identified
to our satisfaction, of such documents and corporate and public records as we
deem necessary as a basis for the opinion hereinafter expressed. With respect to
such examination, we have assumed the genuineness of all signatures appearing on
all documents presented to us as originals, and the conformity to the originals
of all documents presented to us as conformed or reproduced copies. Where
factual matters relevant to such opinion were not independently established, we
have relied upon certificates of appropriate state and local officials, and upon
certificates of executive officers and responsible employees and agents of the
Company.

         Based upon the foregoing, it is our opinion that the Shares being
offered in the above-captioned offering, when sold and issued in accordance with
the terms of such offering, will be validly issued, fully paid and
non-assessable.

         Please be advised that we consent to the use of our name under "Legal
Matters" in your Registration Statement on Form SB-2 and Prospectus filed with
the Securities and Exchange Commission.

         By giving this consent, we do not concede that we come within the
categories of persons whose consent is required under the Act or the General
Rules and Regulations promulgated thereunder.


                                            Very truly yours,


                                            Bondy & Schloss LLP


                                      II-8


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission